Research and Markets (http://www.researchandmarkets.com/research/mscd39/atopic_dermatitis) has announced the addition of the "Atopic Dermatitis - Pipeline Review, H2 2015" report to their offering.
This report provides comprehensive information on the therapeutic development for Atopic Dermatitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Atopic Dermatitis and special features on late-stage and discontinued projects.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Key Topics Covered:
- Introduction
- Atopic Dermatitis Overview
- Therapeutics Development
- Pipeline Products for Atopic Dermatitis - Overview
- Pipeline Products for Atopic Dermatitis - Comparative Analysis
- Atopic Dermatitis - Therapeutics under Development by Companies
- Atopic Dermatitis - Therapeutics under Investigation by Universities/Institutes
- Atopic Dermatitis - Pipeline Products Glance
- Late Stage Products
- Clinical Stage Products
- Early Stage Products
- Atopic Dermatitis - Products under Development by Companies
- Atopic Dermatitis - Products under Investigation by Universities/Institutes
- Atopic Dermatitis - Companies Involved in Therapeutics Development
Companies Mentioned - Partial List
- Abeome Corporation
- AlbireoPharma
- Almirall, S.A.
- Amgen Inc.
- Amorepacific Corporation
- Anacor Pharmaceuticals, Inc.
- AnaMar AB
- AnaptysBio, Inc.
- AnGes MG, Inc.
- Aquinox Pharmaceuticals Inc.
- arGEN-X BV
- Blueberry Therapeutics Ltd
- Brickell Biotech, Inc.
- Celgene Corporation
- ChemoCentryx, Inc.
- ChironWells GmbH
- Chugai Pharmaceutical Co., Ltd.
- Creabilis SA
- Delenex Therapeutics AG
- Dermira Inc.
- Dr. August Wolff GmbH & Co. KG Arzneimittle
- Eisai Co., Ltd.
- F. Hoffmann-La Roche Ltd.
- Foamix Pharmaceuticals Ltd.
- Fountain Biopharma Inc.
- GlaxoSmithKline Plc
- Glenmark Pharmaceuticals Ltd.
- Grupo Ferrer Internacional, S.A.
- Han Wha Pharma Co., Ltd.
- HanAll Biopharma Co., Ltd.
- Herantis Pharma Plc
- iCo Therapeutics Inc.
- IMMD Inc.
- Immune Pharmaceuticals Inc.
- Inflamalps SA
For more information visit http://www.researchandmarkets.com/research/mscd39/atopic_dermatitis
View source version on businesswire.com: http://www.businesswire.com/news/home/20160114005622/en/
